Item 2.02. Results of Operations and Financial Condition.
On
The information in Item 2.02 of this Current Report on Form 8-K, including the sections of the Press Release incorporated by reference herein, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 8.01. OTHER EVENTS.
The information set forth in the Press Release, solely to the extent such
information references the orders for 76 Revio systems received by the Company
in the fourth quarter, the Company's anticipated timing for the commercial
launches of the Revio and Onso systems, and the Company's expectations for
preliminary fourth quarter revenue and preliminary cash, cash equivalents and
investments balance as of
The portions of the Press Release incorporated by reference into Item 8.01 of this Current Report on Form 8-K are being filed pursuant to Item 8.01. The remaining portions of the Press Release are being furnished pursuant to Item 2.02 of this Current Report on Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Because the Company's financial statements as of and for the quarter ended
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS. 5 (d) Exhibits. Exhibit No. Description 99.1 Press Release issued byPacific Biosciences of California, Inc. , datedJanuary 9, 2023 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) ?
--------------------------------------------------------------------------------
© Edgar Online, source